HOME > TOP STORIES

TOP STORIES

REGULATORY PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment

January 28, 2013
BUSINESS Novartis, Sanofi Dissolve Partnership on Equa Copromotion

January 25, 2013
BUSINESS Transparency GL: Drug Makers Might Disclose Individual Payments Only Upon Request

January 24, 2013
BUSINESS Merck Serono Aims for Top 10 Slot in Oncology Field

January 23, 2013
BUSINESS Sanofi’s Dellegra Promotion to Home in on Stuffy Nose

January 22, 2013
BUSINESS Pfizer Detailing Infectious Disease Portfolios across Divisions

January 21, 2013
BUSINESS Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development

January 21, 2013
ORGANIZATION JPMA Bolstering ICH Activities to Propose New Topics from Industry

January 18, 2013
BUSINESS Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013

January 18, 2013
BUSINESS OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs

January 17, 2013
BUSINESS Domestic Drug Makers Working to Escape Dependence on Long-Listed Drugs through New Product Development

January 17, 2013
BUSINESS GMP Violations at Drug Substance Makers Prompt Series of New Voluntary Recalls of Generics; Stable Supplies Disrupted

January 16, 2013
ORGANIZATION JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers

January 15, 2013
REGULATORY Focus May Be on Whether New Price Cutting Rule for Long-Listed Drugs Should Apply Only to Those Granted Premium

January 15, 2013
REGULATORY PMDA Probes How Insurance Pharmacies Utilize Drug Safety Information

January 11, 2013
BUSINESS Takeda to Pitch Lotriga for Patients with Residual Event Risks, Cultivate New Market

January 10, 2013
BUSINESS AbbVie to Focus on Specialty Care, “Not Interested” in Established Markets: CEO Winer

January 9, 2013
ORGANIZATION Efforts to Promote Generic Substitution Preferable to Cutting Prices of Long-Listed Drugs: Mr Sawai of JGA

January 8, 2013
BUSINESS “Appropriate Expressions” of Disease Awareness Ads Being Tested

January 7, 2013
ORGANIZATION Member Companies to Begin Enforcing New COP in FY2013: JPMA President Teshirogi

January 7, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…